Novo Nordisk Unveils New Strength of Wegovy With Significant Weight Loss Results Novo Nordisk, a leading pharmaceutical company, has announced plans to seek approval from the UKs Medicines and Healthcare products Regulatory Agency (MHRA) for a new 7.2mg dose of its weight-loss drug Wegovy (semaglutide)
Why the combo works: Theanine takes the edge off any emotional heat that tyrosine might provoke in reactive moments
Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, et al
The company has more than 40 years of experience in clinical ingredient selection and advanced powder technologies and is ISO 22000-certified for production in France
However, berberine is not recommended as monotherapy for type 2 diabetes or obesity requiring significant metabolic intervention, and its effects plateau at modest levels